GLP1 Agonists and Weight Management: The Current Status Quo and Black-Market Trade
Weight issues, obesity, hunger, and medical co-morbidities with reference to the use of Glucagon-like peptide 1 Receptor Agonists (GLP1) have taken the world by storm.
The efficiency of these once weekly injections for weight loss is not in question. Losing 10-20% of body mass is very achievable, but there are some very serious concerns that have recently come to light.